Mani Chandran
Overview
Explore the profile of Mani Chandran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ponirakis G, Hamad H, Al-Waisy A, Petropoulos I, Khan A, Gad H, et al.
Alzheimers Dement (N Y)
. 2025 Jan;
11(1):e70025.
PMID: 39759948
Introduction: Corneal confocal microscopy (CCM) detects neurodegeneration in mild cognitive impairment (MCI) and dementia and identifies subjects with MCI who develop dementia. This study assessed whether abnormalities in corneal endothelial...
2.
Hamad H, Chandran M, Manikoth P, Davis D, Sathian B
Nepal J Epidemiol
. 2024 Sep;
14(2):1342-1343.
PMID: 39279991
No abstract available.
3.
Hamad H, Nadukkandiyil N, Chandran M, Manikoth P, Sathian B
Nepal J Epidemiol
. 2024 Sep;
14(2):1323-1332.
PMID: 39279989
Background: The Global Dementia Observatory (GDO) is a monitoring and accountability tool for the Global Action Plan on Public Response to Dementia 2017-25. Evidence from dementia registries may be utilized...
4.
Elawady M, AlHamad H, Valappil S, Abbas A, Chandran M, Manikoth P, et al.
J Gerontol Nurs
. 2024 May;
50(6):6-9.
PMID: 38815227
Purpose: To implement the Age-Friendly Health Systems (AFHS) 4Ms framework, focusing on Medication and its impact on Mobility, Mentation, and What Matters, within Hamad Medical Corporation in Qatar. Method: A...
5.
Al-Akl N, Khalifa O, Ponirakis G, Parray A, Ramadan M, Khan S, et al.
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38396924
Diabetes is recognized as a risk factor for cognitive decline, but the underlying mechanisms remain elusive. We aimed to identify the metabolic pathways altered in diabetes-associated cognitive decline (DACD) using...
6.
Ehtewish H, Mesleh A, Ponirakis G, Lennard K, Hamad H, Chandran M, et al.
Front Neurol
. 2023 Dec;
14:1256745.
PMID: 38107644
Background: Dementia is a debilitating neurological disease affecting millions of people worldwide. The exact mechanisms underlying the initiation and progression of the disease remain to be fully defined. There is...
7.
Al-Khawaga S, Akram W, Hussain K, Chandran M, Buddenkotte J, Joy F, et al.
Qatar Med J
. 2023 Nov;
2023(2):12.
PMID: 38025342
The 'GeriDerm' (geriatric dermatology) clinic, is a new dermatology-based service at Hamad Medical Corporation (HMC), accommodating the needs of our elderly population living in the State of Qatar. Due to...
8.
Ehtewish H, Mesleh A, Ponirakis G, de la Fuente A, Parray A, Bensmail I, et al.
Int J Mol Sci
. 2023 May;
24(9).
PMID: 37175824
Dementia is a progressive and debilitating neurological disease that affects millions of people worldwide. Identifying the minimally invasive biomarkers associated with dementia that could provide insights into the disease pathogenesis,...
9.
Ponirakis G, Hamad H, Omar D, Petropoulos I, Khan A, Gad H, et al.
Ann Clin Transl Neurol
. 2023 Feb;
10(4):599-609.
PMID: 36852724
Objectives: This study compared the utility of corneal nerve measures with brain volumetry for predicting progression to dementia in individuals with mild cognitive impairment (MCI). Methods: Participants with no cognitive...
10.
Ponirakis G, Hamad H, Khan A, Petropoulos I, Gad H, Chandran M, et al.
Alzheimers Dement (N Y)
. 2022 Apr;
8(1):e12269.
PMID: 35415208
Introduction: This study compared the capability of corneal confocal microscopy (CCM) with magnetic resonance imaging (MRI) brain volumetry for the diagnosis of mild cognitive impairment (MCI) and dementia. Methods: In...